Memorial Sloan-Kettering Cancer Center Rockville Centre: Clinical Trials at Rockville Centre

Browse our continually updated listing of clinical trials available to patients at Memorial Sloan-Kettering Cancer Center Rockville Centre below. You can also explore our complete listing of clinical trials available at Memorial Sloan-Kettering.

Showing 21 - 40 of 77 trials
Titlesort icon Investigator Disease(s)
A Phase II Study of Everolimus as Second-Line Therapy in the Treatment of Metastatic Renal Cell Carcinoma
[Protocol 11-197] 		Motzer, Robert
  • Kidney Cancer
A Phase II Study of Fulvestrant Alone or with GDC-0941 or GDC-0980 in Women with Advanced Breast Cancer Resistant to Aromatase Inhibitor Therapy
[Protocol 12-029] 		Dickler, Maura
  • Breast Cancer
A Phase II Study of Gemcitabine and Cisplatin before Surgery in Patients with High-Grade Upper Tract Urothelial Carcinoma
[Protocol 10-208] 		Coleman, Jonathan
  • Kidney Cancer
A Phase II Study of Gemcitabine and Pazopanib in Previously Untreated Patients with Advanced Urothelial Cancers Who Cannot Receive Cisplatin
[Protocol 11-191] 		Bajorin, Dean
  • Bladder Cancer
  • Kidney Cancer
A Phase II Study of Hepatic Arterial Infusion and Intravenous Chemotherapy with or without Panitumumab in Patients with Normal KRAS with Resected Liver Metastases from Colorectal Cancer
[Protocol 10-137] 		Kemeny, Nancy
  • Colorectal Cancer
A Phase II Study of IZN-6N4 to Reduce Mouth Sores in Patients with Head and Neck Cancer Receiving Chemotherapy and Radiation Therapy
[Protocol 12-204] 		Lee, Nancy
  • Head & Neck Cancer
A Phase II Study of Lenalidomide Intensification in Patients with Asymptomatic Multiple Myeloma that Has Progressed with Lenalidomide Maintenance Therapy after Autologous Stem Cell Transplantation
[Protocol 11-107] 		Hassoun, Hani
  • Hematology
    • Multiple Myeloma
A Phase II Study of mFOLFOX6 with Bevacizumab or Tivozanib in Patients with Metastatic Colorectal Cancer
[Protocol 12-066] 		Cercek, Andrea
  • Colorectal Cancer
    • Colon Cancer
A Phase II Study of MLN8237 in Advanced or Metastatic Sarcoma
[Protocol 12-194] 		Dickson, Mark
  • Sarcomas
    • Soft Tissue Sarcoma
A Phase II Study of MLN8237 in Patients with Recurrent or Persistent Uterine Leiomyosarcoma
[Protocol 12-164] 		Hyman, David
  • Endometrial and other Uterine Cancers
    • Leiomyosarcoma
    • Uterine Cancer
  • Leiomyosarcoma
  • Sarcomas
    • Leiomyosarcoma
    • Soft Tissue Sarcoma
A Phase II Study of Neoadjuvant Dose-Dense Gemcitabine and Cisplatin in Patients with Muscle-Invasive Bladder Cancer
[Protocol 12-071] 		Bajorin, Dean
  • Bladder Cancer
A Phase II Study of Neoadjuvant Pemetrexed Plus Cisplatin for Patients with Resectable Non-Squamous Non-Small Cell Lung Cancer with "Switch Chemotherapy Alternative" in Non-Responders (NEOSCAN)
[Protocol 11-106] 		Chaft, Jamie
  • Lung Cancer
  • Lung Cancer, Non-Small Cell
    • Lung Adenocarcinoma
A Phase II Study of Paclitaxel, Trastuzumab, and Pertuzumab for the Treatment of Metastatic HER2-Positive Breast Cancer
[Protocol 10-142] 		Dang, Chau
  • Breast Cancer
A Phase II Study of Partial Breast Irradiation for Select Patients with Early Invasive or Noninvasive Breast Cancer
[Protocol 10-114] 		Powell, Simon
  • Breast Cancer
A Phase II Study of PET Scan-Directed Combined Modality Therapy for Esophageal Cancer
[Protocol 12-011] 		Ilson, David
  • Upper Gastrointestinal
    • Esophageal Cancer
A Phase II Study of Repeat Breast-Preserving Surgery and 3D-Conformal Partial Breast Re-Irradiation for Local Recurrence of Breast Cancer
[Protocol 10-152] 		McCormick, Beryl
  • Breast Cancer
A Phase II Study of Secondary Cytoreduction with and without HIPEC plus Postoperative Chemotherapy for Women with Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
[Protocol 12-275] 		Chi, Dennis
  • Ovarian Cancer
A Phase II Study of Siltuximab in Patients with High-Risk Smoldering Multiple Myeloma
[Protocol 12-068] 		Lesokhin, Alexander
  • Hematology
    • Multiple Myeloma
A Phase II Study of Temozolomide Alone or with ABT-888 (Veliparib) in Patients with Relapsed or Refractory Small Cell Lung Cancer
[Protocol 12-021] 		Pietanza, M. Catherine
  • Lung Cancer
  • Lung Cancer, Small Cell
    • Other
A Phase II Study of Vemurafenib in Patients with BRAF V600 Mutation-Positive Cancers
[Protocol 12-131] 		Hyman, David
  • Hematology
    • Hematologic Disorders
    • Multiple Myeloma